𝔖 Bobbio Scriptorium
✦   LIBER   ✦

623 Has the Model of End Stage Liver Disease (MELD) Improved Racial Disparities in Graft Survival for Liver Transplant Recipients?

✍ Scribed by Jonassaint, Naudia L.; Yenokyan, Gayane; Boulware, L. Ebony

Book ID
123258369
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
108 KB
Volume
144
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The pediatric end-stage liver disease (P
The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients
✍ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr

A systematic review of the performance o
A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation
✍ Evangelos Cholongitas; Laura Marelli; Vibhakorn Shusang; Marco Senzolo; Keith Ro πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 1 views

The Model for End-Stage Liver Disease (MELD) score is now used for allocation in liver transplantation (LT) waiting lists, replacing the Child-Turcotte-Pugh (CTP) score. However, there is debate as whether it is superior to CTP score to predict mortality in patients with cirrhosis on the LT waiting